Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,991,660
New position
Shares Held
5,500
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#1,281
of 3,140 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOCHK Asset Management Ltd holds $32,542,832 across 7 Drug Manufacturers - General names. AMGN ranks #6 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
41,590 | $10,465,707 | |
| 2 | LLY |
ELI LILLY & Co
|
6,610 | $7,928,232 | |
| 3 | MRK |
Merck & Co., Inc.
|
44,360 | $5,700,260 | |
| 4 | JNJ |
Johnson & Johnson
|
15,290 | $3,883,201 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
19,800 | $2,501,532 | |
| 6 | AMGN |
Amgen Inc
This page
|
5,500 | $1,991,660 | |
| 7 | PFE |
Pfizer Inc
|
3,000 | $72,240 |
All Filings in AMGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,991,660 | 5,500 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||